Navigation Links
Data to Be Presented at 58th Annual Meeting of The American Society of Human Genetics
Date:11/6/2008

NOVATO, Calif., Nov. 6 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that data from clinical studies of Kuvan(R) (sapropterin dihydrochloride), Naglazyme(R) (galsulfase) and enzyme replacement therapies for MPS IVA (Morquio Syndrome) and Pompe disease will be presented at the 58th Annual Meeting of the American Society of Human Genetics (ASHG) in Philadelphia, Pennsylvania, November 11-15, 2008.

"We look forward to a number of poster presentations that will address a variety of investigator-sponsored trials now in progress. Results from these studies will add to our growing data set for Kuvan and Naglazyme and increase our understanding about the long term safety and efficacy of the drugs across different patient populations," said Chief Medical Officer Emil Kakkis, M.D., Ph.D.

The following posters will be featured:

590/W - "Implications of absence of clinical phenotype on Morquio A mice: Why rodents do not require skeleton keratan sulfate?"

752/W - "Intrathecal (IT) enzyme replacement therapy (ERT) for symptomatic spinal cord compression (SCC) in a MPS VI child: safety, efficacy, and pitfalls"

763/W - "Therapeutic response after two years of Galsulfase ERT in five adult patients with MPS VI"

2353/W - "MPS Brazil-Network: 4 years improving diagnosis and management of mucopolysaccharidoses in Brazil"

772/T - "PKU treatment with tetrahydrobiopterin (sapropterin) during pregnancy"

773/T - "A new strategy using sapropterin and placebo to determine the predictive value of mutation analysis towards identifying BH4 responsive hyperphenylalanemia"

774/T - "Interim results of a Phase II, multicenter, open-label study of sapropterin dihydrochlori
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Three Studies by Independent Scientists Highlighting Pressure Cycling Technology (PCT) to be Presented this Week at the British Mass Spectrometry Societys 29th Annual Meeting
2. Survival Data Presented From Phase II Study of Investigational Drug ZD4054 in Hormone-Resistant Prostate Cancer Patients
3. New Data Presented on Immunocytokine Fusion Protein Further Supports Broad Anti-Cancer Potential Of Peregrines Anti-PS Technology Platform
4. Results of Colon Cancer Study Utilizing Pressure Cycling Technology (PCT) Presented at the American College of Gastroenterology Annual Scientific Meeting
5. Kuvan, Naglazyme and Aldurazyme Data to Be Presented at the 57th Annual Meeting of the American Society of Human Genetics
6. Micromet Data Presented at the International AACR-NCI-EORTC Conference Support the Development of Adecatumumab (MT201) in Earlier Stage Cancer Disease Settings
7. Three PDX (Pralatrexate) Studies Presented at the 2007 AACR-NCI-EORTC Conference
8. Salugens Award-Winning Research on Using DNA Information to Customize Nutritional Supplementation for Weight Loss Presented at the Second Annual Bruce Ames International Symposium on Nutritional Genomics at the University of California, Davis
9. Reverse Cholesterol Transport by RVX-208 a Small Molecule for ApoA-I Production Increase Presented at American Heart Association Scientific Meeting
10. Genasense(R) Triple Combination Therapy in Advanced Melanoma Presented at Chemotherapy Foundation Symposium
11. Promising Data ATIR Studies Presented by NIH Investigators

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)..., QUINCY, Mass., Nov. 6 Myriant...iotech developer and manufacturer of renewable bi...referred technology provider Uhde GmbH, one of the..."Uhde"), announced an alliance for the engineering...s biobased Succinic Acid plants based on renewable...
(Date:11/6/2009)..., SAN MATEO, Calif., Nov. 6 /PRNewswire-FirstCa... Completed transfer of Qutenza(TM) E.U. Marketing...de significant progress in commercial readiness ac...ales; Senior Director, Marketing; and Director, Co... to board as director and Audit Committee chairman...
(Date:11/6/2009)..., CALGARY, Nov. 6 /PRNewswire-FirstCall/ - Onco...ytics" or the "Company") today announced updated r...IN(R) in patients with sarcomas metastatic to the ...onnective Tissue Oncology Society Meeting held in ...e poster presentation, entitled "A Phase II Study ...
(Date:11/6/2009)... The agenda for Arrowhead&...nference, which is set to take place on February 2... this three day conference we will highlight key i...speakers to share their experiences. , ...2009 -- The agenda for Arrowhead’s 2010 Per...
Breaking Biology Technology:Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3
...rchTechnology,Inc. (eRT), (Nasdaq: ERES ), a lead...ECG) collection and interpretation services,announ...ter results for the,period ended March 31, 2008 on... the release, the Company will host a conference c...ence call interested participants should dial,800-...
... Therapeutics,Inc. (Nasdaq: IMRX ) today announce...t Laboratories pursuant to which it has satisfied ... promissory note with Abbott issued in,connection ...ll title to,the urokinase assets, including the re...ory and clinical documentation, validated cell lin...
...hering-Plough,Corporation (NYSE: SGP ) today anno...cts from 12 product franchises in Europe. These ag...th by the European Commission as part,of its Octob... of the,Intervet animal health business from Akzo ...d Virbac, a French animal health,company, will acq...
Other Biology Technology:eResearchTechnology, Inc. to Announce 2008 First Quarter Results on May 5, 2008 2ImaRx Therapeutics Satisfies Abbott Note Obligation Associated With the Acquisition of Urokinase 2ImaRx Therapeutics Satisfies Abbott Note Obligation Associated With the Acquisition of Urokinase 3Schering-Plough Announces Planned Divestiture of Select Animal Health Products in Europe 2
(Date:11/9/2009)...arge blooms of tiny marine plants called phytoplan...xposed by the recent and rapid melting of ice shel...his remarkable colonisation is having a beneficial...phytoplankton sinks to the sea-bed where it can st... Reporting this week in the journal Global Chang...
(Date:11/9/2009)...he Springer journal Naturwissenschaften is publi...Darwin and Modern Biology" to commemorate Darwin,s...years ago in November 1859. Guest editor and autho...fessor of plant physiology and evolutionary biolog...cles in this special issue are available free of c...
(Date:11/9/2009)... A chemical culprit responsible for the rapid, mys...ic Ocean has been found by collaborating scientist...raphic Institution (WHOI). This same chemical may...he team discovered a previously unknown lipid, or ... and killing Emiliania huxleyi , a phytoplankton ...
Breaking Biology News(10 mins):Antarctica glacier retreat creates new carbon dioxide store 2Newly discovered fat molecule: An undersea killer with an upside 2Newly discovered fat molecule: An undersea killer with an upside 3Newly discovered fat molecule: An undersea killer with an upside 4Mountain States Health Alliance Rolls Out TEDS Talent Management System 53028 1Mountain States Health Alliance Rolls Out TEDS Talent Management System 53028 2Mountain States Health Alliance Rolls Out TEDS Talent Management System 53028 3Mountain States Health Alliance Rolls Out TEDS Talent Management System 53028 4Mountain States Health Alliance Rolls Out TEDS Talent Management System 53028 5New survey report 3A Primary care emphasis included in workplace wellness programs 53025 1New survey report 3A Primary care emphasis included in workplace wellness programs 53025 2New survey report 3A Primary care emphasis included in workplace wellness programs 53025 3New survey report 3A Primary care emphasis included in workplace wellness programs 53025 4New survey report 3A Primary care emphasis included in workplace wellness programs 53025 5This Summer is an Ideal Time for Commercial Real Estate Lease Renewal 53022 1This Summer is an Ideal Time for Commercial Real Estate Lease Renewal 53022 2This Summer is an Ideal Time for Commercial Real Estate Lease Renewal 53022 3
...ate change is the largest environmental change exp...ghts, storms and floods, which will undoubtedly le...icts in the areas migrated to. , In the aftermath...ina in the US, Rafael Reuveny from Indiana Univers...egradation on population migration, or ecomigratio...
...ING carbon dioxide deep below the earths surface c...lanets major contributors to climate change. , Un...tone, drained of oil by the energy giants, could p...udy found that sandstone reacts with injected flui...ctions are essential if the captured CO2 is not to...
...s release is also available in French . , Ecol... "pristine" ecosystems while ignoring the overwhel...esearchers from McGill University and the Universi...Erle Ellis of UMBC and Prof. Navin Ramankutty of M...g ecosystems into biomes (or "ecological communiti...
Other Biology News:Environmental exodus 2Planting carbon deep in the earth -- rather than the greenhouse 2Environmental researchers propose radical 'human-centric' map of the world 2
Rabbit Anti-Human DNase II Polyclonal Antibody, Unconjugated from Calbiochem
BD BioCoat Poly-D-Lysine 60 mm Culture Dishes from BD Biosciences - Discovery Labware
BD BioCoat Collagen I 60 mm Culture Dishes from BD Biosciences - Discovery Labware
Corning C ulture Dishes,100X20 mm,55Cm2,Sterile,6-Pack Carrier (6Pks Of 10 Dishes) from Sigma-Aldrich
Biology Products: